24
Oct
2023

Mipharm S.p.A

Exhibitor at CPHI Barcelona 2023 stand 3S10, Pharma Machinery and Equipment
About Us

Mipharm S.p.A. was born in January 1998 following the merger of Sandoz and Ciba Geigy, from which resulted the new company Novartis. Mipharm was founded by a group of ex managers coming from Novartis by mean of a spin-off of the manufacturing site located in Milan, Via Quaranta, previously owned by Sandoz. 
In December 2016, Mandarin Capital Partners II acquired the majority stake in Mipharm share capital.
Today, Mipharm is one of the most valuable third party manufacturing and new product development sites in Italy and it claims to have four FDA approvals (Nasal...

  • IT
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
Wholesale/Retail
Contact info
Event information
CPHI Barcelona 2023
  • 24-26 October 2023
  • Fira Barcelona Gran Via, Spain
  • Visit us at stand 3S10, Pharma Machinery and Equipment

Products Featured at CPHI Barcelona 2023

  • 1 Marchesini Gamma line

    Product 1 Marchesini Gamma line

    Mipharm S.P.A offers a wide range of products which includes 1 marchesini gamma line. It belongs to packaging category. Contact us for more information.
  • 1 Marchesini MB440

    Product 1 Marchesini MB440

    Mipharm S.P.A offers a wide range of products which includes 1 marchesini mb440. It belongs to packaging category. Contact us for more information.
  • 1 Marchesini MS235

    Product 1 Marchesini MS235

    Mipharm S.P.A offers a wide range of products which includes 1 marchesini ms235. It belongs to sachet category. Contact us for more information.
  • 100/550 I compounding vessels

    Product 100/550 I compounding vessels

    Mipharm S.P.A offers a wide range of products which includes 100/550 i compounding vessels. It belongs to nasal spray solutions category. Contact us for more information.
  • 2 Marchesini MB421

    Product 2 Marchesini MB421

    Mipharm S.P.A offers a wide range of products which includes 2 marchesini mb421. It belongs to packaging category. Contact us for more information.